Osaka, Japan & Cambridge, Mass., United States:The Phase 3 GRAPHITE Study Met Its Primary Efficacy Endpoint of Significant and Clinically Meaningful Intestinal...
New Delhi:The Drugs Controller General of India has approved Itolizumab for restricted emergency use on COVID-19 patients with moderate to severe acute respiratory distress...